Structure and design of polymeric surfactant-based drug delivery systems

Journal of Controlled Release - Tập 73 Số 2-3 - Trang 137-172 - 2001
V.P. Torchilin1
1Department of Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, 360 Huntington Avenue, Boston, MA 02129, USA. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

R.H. Müller, Colloidal Carriers for Controlled Drug Delivery and Targeting, Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany, and CRC Press, Boca Raton, FL, 1991.

1995

1996

Torchilin, 1995, Which polymers can make nanoparticulate drug carriers long-circulating?, Adv. Drug Deliv. Rev., 16, 141, 10.1016/0169-409X(95)00022-Y

Torchilin, 1996, How do polymers prolong circulation time of liposomes?, J. Liposome Res., 6, 99, 10.3109/08982109609037204

1996

Palmer, 1984, The mechanism of liposome accumulation in infarction, Biochim. Biophys. Acta, 797, 363, 10.1016/0304-4165(84)90258-7

Gabizon, 1995, Liposome circulation time and tumor targeting: implications for cancer chemotherapy, Adv. Drug Delivery Rev., 16, 285, 10.1016/0169-409X(95)00030-B

Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Contr. Rel., 65, 271, 10.1016/S0168-3659(99)00248-5

Klibanov, 1990, Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett., 268, 235, 10.1016/0014-5793(90)81016-H

Torchilin, 1994, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochim. Biophys. Acta, 1195, 11, 10.1016/0005-2736(94)90003-5

Torchilin, 1994, Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo, Biochim. Biophys. Acta, 1195, 181, 10.1016/0005-2736(94)90025-6

Papisov, 1995, Modeling in vivo transfer of long-circulating polymers (two classes of long-circulating polymers and factors affecting their transfer in vivo), Adv. Drug Deliv. Rev., 16, 127, 10.1016/0169-409X(95)00021-X

Allen, 1994, The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system, Adv. Drug Deliv. Rev., 13, 285, 10.1016/0169-409X(94)90016-7

Allen, 1995, Pharmacokinetics of long-circulating liposomes, Adv. Drug Deliv. Rev., 16, 267, 10.1016/0169-409X(95)00029-7

Hwang, 1987, Liposome pharmacokinetics, 109

Harper, 1991, Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro, Biomaterials, 12, 695, 10.1016/0142-9612(91)90119-U

Gref, 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245

Gref, 1995, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres, Adv. Drug Deliv. Rev., 16, 215, 10.1016/0169-409X(95)00026-4

Torchilin, 1992, Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium, FASEB J., 6, 2716, 10.1096/fasebj.6.9.1612296

Torchilin, 1994, Why do polyethylene glycol-coated liposomes circulate so long?, J. Liposome Res., 4, 725, 10.3109/08982109409037068

Blume, 1993, Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times, Biochim. Biophys. Acta, 1149, 180, 10.1016/0005-2736(93)90039-3

Allen, 1994, Antibody-mediated targeting of long-circulating (Stealth®) liposomes, J. Liposome Res., 4, 1, 10.3109/08982109409037027

Hansen, 1995, Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures, Biochim. Biophys. Acta, 1239, 133, 10.1016/0005-2736(95)00138-S

Torchilin, 2000, PEG-immunoliposomes: attachment of monoclonal antibodies to distal ends of PEG chains via p-nitrophenylcarbonyl groups, 217

1991, Vols. 1–3

Turro, 1984, Photoluminescent probes for water soluble polymers. Pressure and temperature effect on a polyol surfactant, Macromolecules, 17, 2123, 10.1021/ma00140a043

Astafieva, 1993, Critical micellization phenomena in block polyelectrolyte solution, Macromolecules, 26, 7339, 10.1021/ma00078a034

Jones, 1999, Polymeric micelles — a new generation of colloidal drug carriers, Eur. J. Pharm. Biopharm., 48, 101, 10.1016/S0939-6411(99)00039-9

Martin, 1993, 396

1968

1983

1993

Kabanov, 1992, A new class of drug carriers; micelle poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood to brain, J. Contr. Rel., 22, 141, 10.1016/0168-3659(92)90199-2

Trubetskoy, 1995, Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents, Adv. Drug Deliv. Rev., 16, 311, 10.1016/0169-409X(95)00032-3

Kwon, 1995, Block copolymer micelles as long-circulating drug vehicles, Adv. Drug Deliv. Rev., 16, 295, 10.1016/0169-409X(95)00031-2

Charman, 1992, Lipid vehicle and formulation effects on intestinal lymphatic drug transport, 113

Muranishi, 1990, Absorption enhancers, Crit. Rev. Ther. Drug Carrier Syst., 7, 1

Muranishi, 1981, Effect of fatty acids and monoglycerides on permeability of lipid bilayer, Chem. Phys. Lipids, 28, 269, 10.1016/0009-3084(81)90013-X

Saletu, 1988, Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping, Int. Clin. Psychopharmacol., 3, 287, 10.1097/00004850-198810000-00002

Kabanov, 1989, The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles, FEBS Lett., 258, 343, 10.1016/0014-5793(89)81689-8

Martinez-Coscolla, 1993, Studies on the reliability of novel absorption–lipophilicity approach to interpret the effects of the synthetic surfactants on drug and xenobiotics absorption, Drug. Res., 43, 699

Masuda, 1986, The mode of enhanced enteral absorption of macromolecules by lipid-surfactant mixed micelles, J. Pharmacobio.-Dyn., 9, 793, 10.1248/bpb1978.9.793

Lasic, 1992, Mixed micelles in drug delivery, Nature, 355, 279, 10.1038/355279a0

Tengamnuay, 1990, Bile salt–fatty acid mixed micelles as nasal absorption promoters of peptides, Pharm. Res., 7, 127, 10.1023/A:1015868516602

Magnusson, 1986, Toxicity of Pluronic F-68, Toxicol. Lett., 30, 203, 10.1016/0378-4274(86)90156-6

Schmolka, 1977, A review of block polymer surfactants, J. Am. Oil Chem. Soc., 54, 110, 10.1007/BF02894385

Port, 1978, The effect of Pluronic F-38 (poloxamer 108) administered intravenously in rats, Toxicol. Appl. Pharmacol., 44, 401, 10.1016/0041-008X(78)90200-4

Yokoyama, 1992, Block copolymers as drug carriers, CRC Crit. Rev. Ther. Drug Carrier Syst., 9, 213

Zhang, 1995, Multiple morphologies of ‘crew-cut’ aggregates of polystyrene-b-poly(acrylic acid) block copolymers, Science, 268, 1728, 10.1126/science.268.5218.1728

Kataoka, 1993, Block-copolymer micelles as vehicles for drug delivery, J. Contr. Rel., 24, 119, 10.1016/0168-3659(93)90172-2

Gao, 1993, A model of micellization for block copolymers in solutions, Macromolecules, 26, 7353, 10.1021/ma00078a035

Winnik, 1992, Amphiphilic poly(N-isopropylacrylamide) prepared by using a lipophilic radical initiator: synthesis and solution properties in water, Macromolecules, 25, 1876, 10.1021/ma00033a006

Yokoyama, 1994, Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin, J. Contr. Rel., 32, 269, 10.1016/0168-3659(94)90237-2

La, 1996, Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(-benzyl L-aspartat) block copolymer micelles, J. Pharm. Sci., 85, 85, 10.1021/js950204r

Chung, 1998, Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core–shell micellar drug carriers, J. Contr. Rel., 53, 119, 10.1016/S0168-3659(97)00244-7

Marques, 1997, Bunchy micelles, Langmuir, 13, 1430, 10.1021/la960048j

Bader, 1984, Water soluble polymers in medicine, Angew. Chem., 123/124, 457, 10.1002/apmc.1984.051230121

Alakhov, 1998, Block copolymeric biotransport carriers as versatile vehicles for drug delivery, Expert. Op. Invest. Drugs, 7, 1453, 10.1517/13543784.7.9.1453

Kwon, 1998, Diblock copolymer nanoparticles for drug delivery, Crit. Rev. Ther. Drug Carrier Syst., 15, 481, 10.1615/CritRevTherDrugCarrierSyst.v15.i5.20

Schild, 1991, Microheterogenous solutions of amphiphilic copolymers of N-isopropylacrylamide. An investigation via fluorescence methods, Langmuir, 7, 1319, 10.1021/la00055a005

Ringsdorf, 1991, Fluorescence studies of hydrophobically modified poly(N-isopropylacrylamides), Macromolecules, 24, 1678, 10.1021/ma00007a034

Cammas, 1997, Thermoresponsive polymer nanoparticles with a core–shell micelle structure as site specific drug carriers, J. Contr. Rel., 48, 157, 10.1016/S0168-3659(97)00040-0

Torchilin, 1995, New synthetic amphiphilic polymers for steric protection of liposomes in vivo, J. Pharm. Sci., 84, 1049, 10.1002/jps.2600840904

Miller, 1997, Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption, Bioconj. Chem., 8, 649, 10.1021/bc970118d

Katayose, 1998, Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer, J. Pharm. Sci., 87, 160, 10.1021/js970304s

Trubetskoy, 1997, Block copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of a long circulating particulate contrast medium for X-ray computed tomography, J. Drug Targeting, 4, 381, 10.3109/10611869709017895

Yokoyama, 1990, Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer, Cancer Res., 50, 1693

Harada, 1998, Novel polyion complex micelles entrapping enzyme molecules in the core. Preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium, Macromolecules, 31, 288, 10.1021/ma971277v

Kwon, 1997, Block copolymer micelles for drug delivery: loading and release of doxorubicin, J. Contr. Rel., 48, 195, 10.1016/S0168-3659(97)00039-4

Jeong, 1998, Clonazepam release from core-shell type nanoparticles in vitro, J. Contr. Rel., 51, 169, 10.1016/S0168-3659(97)00163-6

Kim, 1998, Methoxy poly(ethylene glycol) and ϵ-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviors, J. Contr. Rel., 51, 13, 10.1016/S0168-3659(97)00124-7

Allen, 1998, Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818, Bioconj. Chem., 9, 564, 10.1021/bc9702157

Ramaswamy, 1997, Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers, J. Pharm. Sci., 86, 460, 10.1021/js960333n

Hagan, 1996, Polylactide-poly(ethylene glycol) copolymers as drug delivery systems, 1. Characterization of water dispersible micelle-forming systems, Langmuir, 12, 2153, 10.1021/la950649v

Kabanov, 1998, Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects, Adv. Drug Deliv. Rev., 30, 49, 10.1016/S0169-409X(97)00106-3

Yu, 1996, Novel morphologies of ‘crew-cut’ aggregates of amphiphilic diblock copolymers in dilute solutions, Langmuir, 12, 5980, 10.1021/la960894u

Nagarajan, 1989, Block copolymer self-assembly in selective solvents: theory of solubilization in spherical micelles, Macromolecules, 22, 4312, 10.1021/ma00201a029

Chubb, 1987, Efficacy of perfluorodecalin as an oxygen carrier for mouse and rat testes perfused in vitro, Proc. Soc. Exp. Biol. Med., 184, 489, 10.3181/00379727-184-42505

Allison AC, 1991, In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443, Mol. Immunol., 28, 279

Topchieva, 1991, Block copolymers of ethylene oxide and propylene oxide (pluronics) as immunomodulators and antitumour agents, Biomed. Sci., 2, 38

Silk, 1972, Effect of Pluronic-F68 on the development of tumor metastasis, Cancer, 25, 171, 10.1002/1097-0142(197201)29:1<171::AID-CNCR2820290126>3.0.CO;2-A

Moore, 1968, Reduction of splenic vascular resistance during perfusion by pluronic F68, J. Surg. Res., 8, 563, 10.1016/0022-4804(68)90010-3

Grover, 1973, A nonionic surfactant and blood viscosity. Experimental observations, Arch. Surg., 106, 307, 10.1001/archsurg.1973.01350150043012

Allen, 1999, Nano-engineering block copolymer aggregates for drug delivery, Coll. Surf. B: Biointerf., 16, 1, 10.1016/S0927-7765(99)00058-2

Inoue, 1998, An AB block copolymers of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs, J. Contr. Rel., 51, 221, 10.1016/S0168-3659(97)00172-7

Mauk, 1980, Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice, Proc. Natl. Acad. Sci. USA, 77, 4430, 10.1073/pnas.77.8.4430

Hunter, 1991, Vol. 1

Kuntz, 1997, Polymeric controlled delivery for immunization, Trends Biotech., 15, 364, 10.1016/S0167-7799(97)01087-1

Gershanik, 1998, Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge, Pharm. Res., 15, 863, 10.1023/A:1011968313933

Cameron, 1999, Asymmetric amphiphilic block copolymers in solution: a morphological wonderground, Can. J. Chem., 77, 1311, 10.1139/cjc-77-8-1311

Zhang, 1996, Ion-induced morphological changes in ‘crew-cut’ aggregates of amphiphilic block copolymers, Science, 272, 1777, 10.1126/science.272.5269.1777

Zhang, 1997, Mesosized crystal-like structure of hexagonally packed hollow hoops by solution self-assembly of diblock copolymers, Phys. Rev. Lett., 79, 5034, 10.1103/PhysRevLett.79.5034

Zhang, 1996, Multiple morphologics and characteristics of ‘crew-cut’ micelle-like aggregates of polystyrene-b-poly(acrylic acid) diblock copolymers in aqueous solution, J. Am. Chem. Soc., 118, 3168, 10.1021/ja953709s

Tian, 1993, Hybridization of block copolymer micelles, Langmuir, 9, 1741, 10.1021/la00031a022

Wang, 1995, Exchange of chains between micelles of labeled polystyrene as monitored by nonradiative singlet energy transfer, Macromolecules, 28, 904, 10.1021/ma00108a016

Creutz, 1998, Dynamics of poly((dimethylamino) alkyl methacrylate) micelles. Influence of hydrophobicity and exchange rate of copolymer molecules, Macromolecules, 31, 681, 10.1021/ma970987y

Kwon, 1993, Biodistribution of micelle-forming polymer-drug conjugates, Pharm. Res., 10, 970, 10.1023/A:1018998203127

Kwon, 1993, Micelles based on AB block copolymers of poly(ethylene oxide) and poly(benzyl-aspartat), Langmuir, 9, 945, 10.1021/la00028a012

Alexandridis, 1994, Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous, Macromolecules, 27, 2414, 10.1021/ma00087a009

Alexandridis, 1994, Surface activity of poly(ethylene oxide-block-poly(propylene oxide)-block-poly(ethylene oxide) copolymers, Langmuir, 10, 2604, 10.1021/la00020a019

Nakamura, 1977, Study of molecular motion of block copolymers in solution by high-resolution proton magnetic resonance, J. Polym. Sci. Polym. Phys. Ed., 15, 2095, 10.1002/pol.1977.180151205

Kwon, 1996, Polymeric micelles as new drug carriers, Adv. Drug Deliv. Rev., 21, 107, 10.1016/S0169-409X(96)00401-2

Blume, 1993, Molecular mechanism of the lipid vesicle longevity in vivo, Biochim. Biophys. Acta, 1146, 157, 10.1016/0005-2736(93)90351-Y

Xing, 1998, Large internal structures of micelles of triblock copolymers with small insoluble molecules in their cores, Langmuir, 14, 4074, 10.1021/la980104b

Nagarajan, 1986, Unusual selectivity in solubilization by block copolymer micelles, Langmuir, 2, 210, 10.1021/la00068a017

Gadelle, 1995, Solubilization of aromatic solutes in block copolymers, Macromolecules, 22, 2403

Teng, 1998, Release kinetics studies of aromatic molecules into water from block polymer micelles, Macromolecules, 31, 3578, 10.1021/ma971721u

Benoit, 1986, Int. J. Pharm., 29, 95, 10.1016/0378-5173(86)90106-7

1992

Zhang, 1997, Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel, Anticancer Drugs, 8, 696, 10.1097/00001813-199708000-00008

Zhang, 1997, An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel, Cancer Chemother. Pharmacol., 40, 81, 10.1007/s002800050630

Lin, 1985, The influence of three poly(oxyethylene)poly(oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin, Pharm. Acta Helv., 60, 339

Lin, 1987, Pluronic surfactants affecting diazepam solubility, compatibility, and adsorption from i.v. admixture solutions, J. Parenter. Sci. Technol., 41, 83

Yokoyama, 1998, Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor, J. Contr. Rel., 50, 79, 10.1016/S0168-3659(97)00115-6

Yokoyama, 1998, Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size, J. Contr. Rel., 55, 219, 10.1016/S0168-3659(98)00054-6

Batrakova, 1996, Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity, Brit. J. Cancer, 74, 1545, 10.1038/bjc.1996.587

Kabanov, 1995, Micelle formation and solubilization of fluorescence probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions, Macromolecules, 28, 2303, 10.1021/ma00111a026

Kabanov, 1995, Water-soluble block polycations as carriers for oligonucleotide delivery, Bioconj. Chem., 6, 639, 10.1021/bc00036a001

Matsumura, 1999, Reduction of the side effects of an antitumor agent, KRN5500, by incorporation of the drug into polymeric micelles, Jpn. J. Cancer Res., 90, 122, 10.1111/j.1349-7006.1999.tb00675.x

Slepnev, 1992, Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymer (pluronic) as a tool for low-molecular compound delivery into a cell: phosphorylation of intracellular proteins with micelle incorporated [gamma-32P]ATP, Biochem. Int., 26, 587

Alakhov, 1996, Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer, Bioconj. Chem., 7, 209, 10.1021/bc950093n

Venne, 1996, Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells, Cancer Res., 56, 3626

Kabanov, 1992, Pluronic micelles as a tool for low-molecular compound vector delivery into a cell: effect of Staphylococcus aureus enterotoxin B on cell loading with micelle incorporated fluorescent dye, Biochem. Int., 26, 1035

Chung, 1997, Reversibly thermo-responsive alkyl-terminated poly(N-isopropylacrylamide) core–shell micelles structures, Coll. Surf. B: Biointerf., 9, 37, 10.1016/S0927-7765(97)00015-5

Chen, 1995, Effect of block size and sequence of the micellization of ABC triblock methacrylic polyampholytes, Macromolecules, 28, 8604, 10.1021/ma00129a020

Kwon, 1994, Enhanced tumor accumulation and prolonged circulation times of micelles-forming poly(ethylene oxide-aspartate) block copolymers-adriamycin conjugates, J. Contr. Rel., 29, 17, 10.1016/0168-3659(94)90118-X

Kwon, 1999, Soluble self-assembled block copolymers for drug delivery, Pharm. Res., 16, 597, 10.1023/A:1011991617857

Allen, 2000, Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone, J. Contr. Rel., 63, 275, 10.1016/S0168-3659(99)00200-X

Seymour, 1998, Cationic block copolymers as self-assembling vectors for gene delivery, 219

Kataoka, 1996, Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline, Macromolecules, 29, 8556, 10.1021/ma961217+

Wolfert, 1996, Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers, Human Gene Ther., 7, 2123, 10.1089/hum.1996.7.17-2123

Katayose, 1997, Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer, Bioconj. Chem., 8, 702, 10.1021/bc9701306

Todd, 1998, Development of adjuvant-active nonionic block copolymers, Adv. Drug Deliv. Rev., 32, 199, 10.1016/S0169-409X(98)00011-8

Hunter, 1984, The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers, J. Immunol., 133, 3167, 10.4049/jimmunol.133.6.3167

Cooper, 1995, The subunit and adjuvant approach, 559

Hunter, 1981, The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile–lipophile balance, J. Immunol., 127, 1244, 10.4049/jimmunol.127.3.1244

Hunter, 1986, The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces, Scand. J. Immunol., 23, 287, 10.1111/j.1365-3083.1986.tb01970.x

Newman, 1997, Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly, Mech. Agening Dev., 93, 189, 10.1016/S0047-6374(96)01811-8

Todd, 1997, Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations, Vaccine, 15, 564, 10.1016/S0264-410X(97)00209-0

Triozzi, 1997, Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer, Clin. Cancer Res., 3, 2355

Helmlinger, 1997, Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation, Nature Med., 3, 177, 10.1038/nm0297-177

Tannock, 1989, Acid pH in tumors and its potential for therapeutic exploitation, Cancer Res., 49, 4373

Kohori, 1998, Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide), J. Contr. Rel., 55, 87, 10.1016/S0168-3659(98)00023-6

Meyer, 1998, Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes, FEBS Lett., 41, 61, 10.1016/S0014-5793(97)01520-2

Cho, 1980, 721

Maruyama, 1995, Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies, Biochim. Biophys. Acta, 1234, 74, 10.1016/0005-2736(94)00263-O

Bendas, 1999, Targetability of novel immunoliposomes prepared by a new antibody conjugation technique, Int. J. Pharm., 181, 79, 10.1016/S0378-5173(99)00002-2

Lasic, 1991, Phase behavior of ‘stealth-lipid’ decithin mixtures, Period. Biol., 93, 287

Trubetskoy, 1995, 452

Trubetskoy, 1996, 781

Yodoya, 1994, Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids, J. Pharm. Exp. Ther., 271, 1509

Samadi-Boboli, 1993, Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice, Br. J. Cancer, 68, 319, 10.1038/bjc.1993.335

Maruyama, 1994, Phosphatidyl polyglycerols prolong liposome circulation in vivo, Int. J. Pharm., 111, 103, 10.1016/0378-5173(94)90407-3

Woodle, 1994, New amphipatic polymer–lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes, Bioconj. Chem., 4, 493, 10.1021/bc00030a001

Whiteman, 2000, Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification, 1160

V.P. Torchilin, T.S. Levchenko, K.R. Whiteman, A.A. Yaroslavov, A.M. Tsatsakis, A.K. Rizos, E.V. Mikhailova, M.I. Shtilman, Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification, Biomaterials, 2001, in press.

Strand, 1979, Quantitative lymphoscintigraphy. I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits, J. Nucl. Med., 20, 1038

Moghimi, 1994, Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes, FEBS Lett., 344, 25, 10.1016/0014-5793(94)00351-3

Tan, 1993, Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interaction with blood components and prolong blood circulation in rats, Biomaterials, 14, 823, 10.1016/0142-9612(93)90004-L

Weissig, 1998, Micellar delivery system for dequalinium — a lipophilic cationic drug with anticarcinoma activity, J. Liposome Res., 8, 391, 10.3109/08982109809035542

Weiss, 1987, Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation, Proc. Natl. Acad. Sci. USA, 84, 5444, 10.1073/pnas.84.15.5444

Teicher, 1986, Intracellular distribution of a platinum–rhodamine 123 complex in cis-platinum sensitive and resistant human squamous carcinoma cell lines, Biochem. Pharm., 35, 3365, 10.1016/0006-2952(86)90437-5

Oseroff, 1986, Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells, L. Cincotta, Proc. Natl. Acad. Sci. USA, 83, 9729, 10.1073/pnas.83.24.9729

Sun, 1994, AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity, Cancer Res., 54, 1465

Weissig, 1998, Accumulation of liposomal- and micellar-bound protein in solid tumor, Pharm. Res., 15, 1552, 10.1023/A:1011951016118

Yuan, 1994, Microvascular permeability and interstitial penetration of sterically-stabilized (stealth) liposomes in human tumor xenograft, Cancer Res., 54, 3352

Yuan, 1995, Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size, Cancer Res., 55, 3752

Hobbs, 1998, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc. Natl. Acad. Sci. USA, 95, 4607, 10.1073/pnas.95.8.4607

Monsky, 1999, Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor, Cancer Res., 59, 4129

Papahadjopoulos, 1991, Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl. Acad. Sci. USA, 88, 11460, 10.1073/pnas.88.24.11460

Parr, 1997, Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol), J. Pharmacol. Exp.Ther., 280, 1319

1995

Trubetskoy, 1996, Polyethyleneglycol-based micelles as carriers of therapeutic and diagnostic drug, STP Pharma. Sci., 6, 79

Schmeidl, 1995, Magnetic resonance imaging of the hepatobiliary system: intestinal absorption studies of manganese mesoporphyrin, Acad. Radiol., 2, 994, 10.1016/S1076-6332(05)80702-0

Lauffer, 1990, Magnetic resonance contrast media: principles and progress, Magn. Res. Quart., 6, 65

Grant, 1989, A liposomal MRI contrast agent: phosphatidyl ethanolamine, Magn. Res. Med., 11, 236, 10.1002/mrm.1910110211

Kabalka, 1989, Gadolinium-labeled liposomes containing paramagnetic amphipatic agents: targeted MRI contrast agent for the liver, Magn. Res. Med., 8, 89, 10.1002/mrm.1910080111

Unger, 1993, Manganese-based liposomes. Comparative approaches, Invest. Radiol., 28, 933, 10.1097/00004424-199310000-00014

Trubetskoy, 1994, New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes, J. Liposome Res., 4, 961, 10.3109/08982109409018613

Slinkin, 1991, Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivity, Bioconj. Chem., 2, 342, 10.1021/bc00011a009

Trubetskoy, 1996, Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging, Acad. Radiol., 3, 232, 10.1016/S1076-6332(96)80448-X

Wolf, 1995, Targeted delivery of imaging agents: an overview, 3

Krause, 1993, Characterization of iopromide liposomes, Invest. Radiol., 28, 1028, 10.1097/00004424-199311000-00011

Seltzer, 1995, Contrast material-carrying liposomes: biodistribution, clearance and imaging characteristics, Radiology, 194, 775, 10.1148/radiology.194.3.7862978

Leander, 1996, A new liposomal contrast medium for CT of the liver: an imaging study in a rabbit tumor model, Acta Radiol., 37, 63, 10.1080/02841859609174361

Torchilin, 1999, CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles, Acad. Radiol., 6, 61, 10.1016/S1076-6332(99)80063-4

Torchilin, 1997, Pharmacokinetic considerations in the development of labeled liposomes and micelles for diagnostic imaging, Quat. J. Nucl. Med., 41, 141

Shin, 1998, Methoxy poly(ethylene glycol) ϵ-caprolactone amphiphilic block copolymeric micelle containing indomethacin, J. Contr. Rel., 51, 1, 10.1016/S0168-3659(97)00164-8

Yokoyama, 1996, Introduction of cisplatin into polymeric micelles, J. Contr. Rel., 39, 351, 10.1016/0168-3659(95)00165-4

Kataoka, 2000, Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance, J. Contr. Rel., 64, 143, 10.1016/S0168-3659(99)00133-9

Yu, 1998, Polymeric micelles for drug delivery: solubilization and hemolytic activity of amphotericin B, J. Contr. Rel., 53, 131, 10.1016/S0168-3659(97)00245-9

Yu, 1998, In vitro dissociation and antifungal efficacy and toxicity of amphotericin B-loaded poly(ethylene oxide)-block-poly(β-benzyl l-aspartate) micelles, J. Contr. Rel., 56, 285, 10.1016/S0168-3659(98)00095-9